Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81
Organisation › Details

BioInvent International AB (OMXS: BINV)

BioInvent International AB develops immune oncology drugs. With one of the world’s largest antibody libraries, and a unique, proprietary discovery method, BioInvent can identify the optimal cellular targets and antibodies for the treatment of various tumor types. BioInvent has also considerable experience in and a facility for process development and production of antibodies for clinical studies. This makes it possible to develop proprietary drug projects, but also to supply leading international pharmaceutical companies with effective tools for their drug development. BioInvent currently has three proprietary projects in or close to clinical development and partnership agreements with seven global pharmaceutical and biotech companies. *

 

Period Start 2004-10-12 existent
Products Industry antibody cancer drug
  Industry 2 n-CoDeR antibody library
Persons Person Welschof, Martin (BioInvent 2019 CEO before Affitech 2002– COO promoted CEO 6/03 before Axaron)
  Person 2 Mathisen, Svein (BioInvent 200510 CEO)
     
Region Region Lund
  Country Sweden
  Street 41 Sölvegatan
  City 223 70 Lund
  Tel +46-46-286-8550
    Address record changed: 2020-06-09
     
Basic data Employees C: 51 to 100 (2016-12-31)
  Currency SEK
  Annual sales 93,740,000 (net sales, consolidated (2019) 2019-12-31)
  Profit -138,633,000 (2019-12-31)
  Cash 153,975,000 (2019-12-31)
     
    * Document for �About Section�: Oncurious N.V.. (5/2/16). "Press Release: Oncurious NV, BioInvent and NMTRC Initiating Phase I/IIa Study with TB-403 for the Treatment of Medulloblastoma". Leuven.
     
   
Record changed: 2020-06-09

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for BioInvent International AB (OMXS: BINV)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81




» top